Healthcare -
Biotechnology - NASDAQ - US
$ 16.5
0.671 %
$ 3.9 B
Market Cap
61.11
P/E
ADMA - CASH FROM FINANCING ACTIVITIES
Cash from Financing Activities ADMA - ADMA Biologics, Inc.
-39 M
LAST VALUE
-14.98%
2 YEAR CAGR
-13.80%
5 YEAR CAGR
-9.20%
10 YEAR CAGR